1. Megaloblastic anemia presenting with skin hyperpigmentation

   • Eleftheria Hatzimichael
   • Evangelos Briasoulis

   Images in Hematology 09 March 2016 Pages: 479 - 480

   

2. Signet ring cell “lymphoma”: mimicking the appearance of signet ring cell carcinoma

   • Kazuya Sakai
   • Naoya Yamasaki
   • Yasunori Ueda

   Images in Hematology 15 March 2016 Pages: 481 - 482

   

3. Multiple myeloma with Russell bodies and needle-shaped crystalline inclusions

   • Toshiki Yamada
   • Yasuhito Nannya
   • Hisashi Tsurumi

   Images in Hematology 16 March 2016 Pages: 483 - 485

   

4. Guest editorial: Institute of Hematology and Blood Diseases Hospital in China

   • Hideo Ema

   Progress in Hematology 10 March 2016 Pages: 486 - 486

5. Cell cycle regulation of hematopoietic stem or progenitor cells

   • Sha Hao
   • Chen Chen
   • Tao Cheng

   Progress in Hematology 23 March 2016 Pages: 487 - 497

   

6. Mechanisms of self-renewal in hematopoietic stem cells

   • Zhao Wang
   • Hideo Ema

   Progress in Hematology 12 December 2015 Pages: 498 - 509

   

7. mTORC signaling in hematopoiesis

   • Xiaomin Wang
   • Yajing Chu
   • Weiping Yuan

   Progress in Hematology 20 January 2016 Pages: 510 - 518

   

8. Novel chemical attempts at ex vivo hematopoietic stem cell expansion

   • Yu Zhang
   • Yingdai Gao

   Progress in Hematology 24 February 2016 Pages: 519 - 529

9. Comparison of myocardial T1 and T2 values in 3 T with T2* in 1.5 T in patients with iron overload and controls

   • Gabriel C. Camargo
   • Tamara Rothstein
   • Ilan Gottlieb

   Original Article 12 February 2016 Pages: 530 - 536

   

10. Iron chelation therapy of transfusion-dependent β-thalassemia during pregnancy in the era of novel drugs: is deferasirox toxic?

    • Michael D. Diamantidis
    • Nikolaos Neokleous
    • Efthymia Vlachaki

    Original Article 09 February 2016 Pages: 537 - 544

    

11. Expression of activated molecules on CD5⁺B lymphocytes in autoimmune hemolytic anemia

    • Hongli Zhu
    • Wenyan Xu
    • Zonghong Shao

    Original Article 11 March 2016 Pages: 545 - 553

    

12. Comparison of three different anti-Xa assays in major orthopedic surgery patients treated with fondaparinux

    • Makoto Ikejiri
    • Hideo Wada
    • Akihiro Sudo

    Original Article 27 February 2016 Pages: 554 - 559

    

13. Fibrin-related markers for diagnosing acute-, subclinical-, and pre-venous thromboembolism in patients with major orthopedic surgery

    • Toshio Yamaguchi
    • Hideo Wada
    • Akihiro Sudo

    Original Article 12 February 2016 Pages: 560 - 566

    

14. Antigen expression on a putative leukemic stem cell population and AML blast

    • Swati Garg
    • Kanjaksha Ghosh
    • Manisha Madkaikar

    Original Article 24 February 2016 Pages: 567 - 571

    

15. The combination effects of bendamustine with antimetabolites against childhood acute lymphoblastic leukemia cells

    • Shoko Goto
    • Hiroaki Goto
    • Tomoko Yokosuka

    Original Article 17 February 2016 Pages: 572 - 583

    

16. In vitro alteration of hematological parameters and blood viscosity by the perfluorocarbon: Oxycyte

    • Françoise Arnaud
    • Katherine Sanders
    • Paula Moon-Massat

    Original Article 17 February 2016 Pages: 584 - 591

    

17. Fatal Cyberlindnera fabianii fungemia in a patient with mixed phenotype acute leukemia after umbilical cord blood transplantation

    • Seiichiro Katagiri
    • Moritaka Gotoh
    • Koichi Makimura

    Case Report 15 February 2016 Pages: 592 - 595

    

18. “Imatinib-induced gastric antral vascular ectasia” in a reporting system of the Japanese Adverse Drug Event Report database

    • Yasuo Oshima
    • Koichiro Yuji
    • Arinobu Tojo

    Letter to the Editor 15 March 2016 Pages: 596 - 598

19. JAK2V617F allele burden in patients with myeloproliferative neoplasms carrying Trisomy 9, and its relationship with clinical phenotypes

    • Mengyun Li
    • Lijun Wen
    • Suning Chen

    Letter to the Editor 18 March 2016 Pages: 599 - 601

20. Erratum to: Successful bypass surgery for esophageal carcinoma under adequate factor XIII/13 replacement therapy in a case of intractable autoimmune hemorrhaphilia due to anti-Factor XIII/13 antibodies

    • Minoru Kojima
    • Akitada Ichinose
    • Kiyoshi Ando

    Erratum 29 March 2016 Pages: 602 - 603